Lexagene Holdings Inc V.LXG

Primary Symbol: LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > Brookline Capital Coverage

<< Previous

Bullboard Posts

Next >>

Comment by Investor62on Jun 23, 2020 3:01am

140 Views

Post# 31179514

RE:RE:RE:RE:RE:RE:Brookline Capital Coverage

Has anyone an insight into the report of the analyst? C$ 2.90 might be ok for an R&D company but in 12 month they should be in production and then this would be far too low. They target at over $ 50B market and considering a 1 % marketshare with their margin (70 %) would get $ 350 Mio Revenue or around $ 3 Rev per share. Or is my calculation totally wrong?

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”